Seth Klarman's The Baupost Group increases its position in Theravance, Inc. (NASDAQ:THRX) It now holds 13,000,000 shares, or 20.44%.
Seth Klarman retweeted
If you're interested in a blog about value investing inspired by Michael Burry and valuestocks.net please visit michaelburry.com
Baupost partially sells its stake in Facet Biotech (NASDAQ:FACT), now holds 2,000,000 shares, or 7.97%. FACT is up 54% YTD.
1
Seth Klarman's The Baupost Group increases its stake in Viasat (NASDAQ:VSAT) to 15.5%, or 4,915,901.
1
The Baupost Group increases its position in Theravance (NASDAQ:THRX). It now holds 10,100,000 shares, or 18.7%.
4
The Baupost Group sells big share of stake on Sapphire Industrials (AMEX:FYR.UN). It now holds 2,250,000 down from 6,200,000 shares.
1
The Baupost Group increases its position on Enzon Pharmaceuticals (NASDAQ:ENZN). It now holds 8,082,400 shares, or 18%.
1
Baupost Increases its position in Capitalsource (NYSE:CSE). It now holds 20,278,400 shares, or 6.3%.
The Baupost Group sells all its stake in RHI Enertainment (NASDAQ:RHIE), or 4,900,551 shares representing 36% ownership.
Baupost files 13D/A on Facet holdings suggesting that they will not accept Biogen's $17.50 tender offer. FACT is 4.5% for the day at $17.12
